| Paul Daniel Mcisaac, PHARMD | |
|
2626 Federal St, Camden, NJ 08105-1936 | |
| (856) 963-0300 | |
| Not Available |
| Full Name | Paul Daniel Mcisaac |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2626 Federal St, Camden, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184061137 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 28RI03314100 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Paul Daniel Mcisaac, PHARMD 2626 Federal St, Camden, NJ 08105-1936 Ph: (609) 330-3712 | Paul Daniel Mcisaac, PHARMD 2626 Federal St, Camden, NJ 08105-1936 Ph: (856) 963-0300 |
News Archive
US Equity Holdings announced yesterday that it has secured funding to launch Aelan Cell Technologies, a biotech startup engaged in the research, discovery, development and commercialization of innovative biomedical technologies and diagnostic tools for the advancement of human health and longevity.
PharmaEssentia Corporation announces presentation of the results of the phase II trial for P1101 + ribavirin in patients with chronic HCV genotype 1 infection at the 25th Conference of the Asian Pacific Association for the Study of the Liver, taking place in Tokyo, Japan from February 20 to 24, 2016 (APASL 2016). Data will be presented by the study coordinating investigator Prof. Wan-Long Chuang (Taiwan) at the HCV parallel oral session on Feb 22nd (15:45-17:45).
Even though there is considerable opinion among Israelis that much of the public social programs and projects should be the responsibility of the government, the public nevertheless views philanthropic activity in a highly positive light and believes that it plays an essential role in Israeli society.
Femara showed reduced risk of death by 13% (P=0.08) versus tamoxifen, despite inclusion of patients who had switched over from tamoxifen to Femara during the study period, following the study's unblinding.
› Verified 9 days ago
Dr. Linda Chuang, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: One Cooper Plaza, Cooper University Hospital Department Of Pharmacy, Camden, NJ 08103 Phone: 856-342-2125 | |
Mrs. Maithili Manchukonda, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 949 N 25th St, Camden, NJ 08105 Phone: 856-963-3000 Fax: 856-963-2000 | |
Mr. Robert Ruggero, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-580-6331 Fax: 856-635-2400 | |
Dr. Jessica Leigh Adams, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz Rm 513, Camden, NJ 08103 Phone: 856-963-3715 | |
Dr. Christina M Morozewicz, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 532 Federal Street, Camden, NJ 08103 Phone: 856-479-9565 Fax: 856-479-9566 | |
Sunil Gada, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3703 Westfield Ave, Camden Discount Pharmacy, Camden, NJ 08105 Phone: 856-963-7899 | |
Rong Li, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1426 Mount Ephraim Ave, Camden, NJ 08104 Phone: 856-541-7648 Fax: 856-541-0195 |